Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker GANX
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 10, 2026 | GANX Gain Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 28, 2026 | GANX Gain Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 1, 2026 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 28, 2026 | GANX Gain Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 11, 2026 | GANX Gain Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 16, 2026 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 29, 2026 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 25, 2026 | GANX Gain Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 26, 2026 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 11, 2026 | GANX Gain Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 26, 2026 | GANX Gain Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 18, 2026 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 18, 2026 | GANX Gain Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 3, 2026 | GANX Gain Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 18, 2025 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 28, 2025 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 12, 2025 | GANX Gain Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 14, 2025 | GANX Gain Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 9, 2025 | GANX Gain Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 6, 2025 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 12, 2025 | GANX Gain Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 17, 2025 | GANX Gain Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 17, 2025 | GANX Gain Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jul 17, 2025 | GANX Gain Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 30, 2025 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 24, 2025 | GANX Gain Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 24, 2025 | GANX Gain Therapeutics, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| May 14, 2025 | GANX Gain Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 10, 2025 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 10, 2025 | GANX Gain Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 27, 2025 | GANX Gain Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 6, 2025 | GANX Gain Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 15, 2025 | GANX Gain Therapeutics, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jan 7, 2025 | GANX Gain Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 7, 2025 | GANX Gain Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 23, 2024 | GANX Gain Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 23, 2024 | GANX Gain Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 14, 2024 | GANX Gain Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
38 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:09 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances